Arrow Percutaneous Sheath Introducer Kit Ak-07903
510(k) K940079
Active
Valid until
No expiry
FDA recalls
1 ongoingDocuments
Trust
Unverified
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK940079 | Date30 Nov 1994 | StatusActive |
Recalls
-
- Ongoing Z-2385-2026
Lidocaine, Bupivacaine, and 0.9% sodium chloride, the subject of a supplier recall, were included into kits and sets. The supplier was found to have quality issues and limited reports of drug ineffectiveness, and if sterility of a water-based injectable product is compromised this could lead to serious or life-threatening injuries.
-
- Terminated Z-2017-2018
- Terminated Z-2018-2018
- Terminated Z-1975-2018
- Terminated Z-1986-2018
Product sterility may be compromised due to unsealed packaging.
-
- Terminated Z-1334-2018
Certain lots of cardiovascular catheters may not be completely sealed and so sterility of the product cannot be guaranteed.
-
- Terminated Z-1160-2018
Products do not contain the Central Venous Catheter Placement Procedures Note or the Central Line Insertion Checklist, which is a tool intended to guide clinicians in the use of best practices during central line insertions.
-
- Terminated Z-0784-2010
Q-Syte Component contained in kits was recalled by manufacturer due to the potential for embolism if used with a central venous catheter.
-
- Terminated Z-1492-2009
Leakage: Material not lipid resistant, may crack and/or leak. Use of this device with lipid containing solutions or 70% isopropyl alcohol may cause leakage or air embolism.
-
- Terminated Z-1035-03
separation of sheath
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- 510(k) Number
- FDA Product Code
- DYB
- Device Class
- Class II
- Regulation
- 21 CFR Part 870.1340
- Advisory Committee
- Cardiovascular
- FDA Decision
- SESE Substantially Equivalent